Dow Jones Top Company Headlines at 5 AM ET: AstraZeneca Books Record Quarterly Revenue as U.S, Oncology Boosts Growth | Stellantis ...

Dow Jones
Jul 29

AstraZeneca Books Record Quarterly Revenue as U.S, Oncology Boosts Growth

The pharmaceutical giant said second-quarter revenue increased to $14.46 billion from $12.94 billion. U.S. revenue was up 13%.

----

Stellantis Reinstates Guidance, Expects Rebound Despite Tariffs

The carmaker now expects to report a sequential improvement in revenue and profitability in the second half of the year.

----

Barclays Beats Views After Trading Activity Boosts Quarterly Results

The lender posted a 28% on-year increase in pretax profit as clients sought to hedge risk and reposition portfolios, boosting trading activity .

----

Berkshire Hathaway Selling Part of Verisign Stake; Stock Falling After-Hours

The price of the offering hasn't been set yet but it could raise $1.2 billion based on Verisign's stock price in after-hours trading.

----

Starbucks Reports Earnings Tuesday. There May Be Some 'Reinvention Fatigue.'

Cafe chain Starbucks will report earnings for the June ended quarter after the market close Thursday.

----

Merck Reports Earnings Tuesday. Key Products Are Under Threat.

There is a growing list of challenges to drugs and programs Merck hopes will take up the slack from Keytruda.

----

Boeing Needs to Show Earnings Progress to Keep Stock Momentum

Boeing reports second-quarter earnings on Tuesday. Wall Street is looking for a per-share loss of $1.40 from sales of $21.7 billion.

----

Whirlpool Cuts Dividend, Full-Year Profit Guidance as Tariffs Hurt Quarterly Results

Appliance maker's CEO says results were affected by foreign competitors stockpiling Asian imports into the U.S. ahead of tariffs.

----

Procter & Gamble Names Jejurikar as CEO

P&G Chief Operating Officer Shailesh Jejurikar will become the company's next chief executive starting at the beginning of next year.

----

Cadence Design Systems Pleads Guilty to Export Violation

The company will pay $140.6 million to settle claims that it illegally exported products to China. Separately, Cadence posted higher revenue in the second quarter and boosted its full-year earnings outlook.

----

Air Canada Posts Lower Profit, Higher Revenue in Second Quarter

The Montreal-based airline logged lower profit and higher revenue in the second quarter and backed its outlook for the full year.

----

UPS's Earnings Are Here. Growth Is Still Missing.

Sales have fallen from a year earlier in 10 of the past 15 quarters.

----

Lululemon Stock Has Rebounded. What to Expect From Earnings.

Investors are looking for evidence that the company's product strategy and holiday momentum can drive a sustained recovery.

----

FIS, Circle Partner to Offer Stablecoin Transactions to Financial Institutions

Through this partnership, the companies will let U.S. financial institutions offer their customers the option to make stablecoin payments in USDC, which is redeemable 1:1 in U.S. dollars.

----

Bristol Myers Squibb and Bain Capital Form New Immunology Company

The company will begin with five potential treatments for autoimmune diseases in-licensed from Bristol Myers Squibb, which will retain 20% equity in the new company.

 

(END) Dow Jones Newswires

July 29, 2025 05:00 ET (09:00 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10